Gülşah Gelişigüzel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Gülşah Gelişigüzel has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Esra Kaya Kiliç
Sağlık Bilimleri Üniversitesi, Ankara Eğitim ve Araştırma Hastanesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniği, Ankara
1 shared publication - Gözde Orman
Department of Ophthalmology, University of Health Sciences Ankara Training and Research Hospital, Ankara, Turkey
1 shared publication - Günay Tuncer Ertem
Department of Infectious Diseases and Clinical Microbiology, Ankara Training and Research Hospital, University of Health Sciences, 06230 Ankara, Türkiye
1 shared publication - Salih Cesur
Department of Infectious Diseases and Clinical Microbiology, Ankara Training and Research Hospital, University of Health Sciences, 06230 Ankara, Türkiye
1 shared publication - Sami Kınıklı
Department of Infectious Diseases and Clinical Microbiology, Ankara Training and Research Hospital, University of Health Sciences, 06230 Ankara, Türkiye
1 shared publication - Sengül Üçer
Department of Infectious Diseases and Clinical Microbiology, Ankara Training and Research Hospital, University of Health Sciences, 06230 Ankara, Türkiye
1 shared publication
Latest Publications
- Open Access
Ocular Syphilis in the Era of Resurgence: Clinical Characteristics and Diagnostic Challenges in a Single-Center Cohort
Background and Objectives: The global resurgence of syphilis has been accompanied by an increasing number of ocular syphilis cases. Ocular syphilis can occur at any stage of infection and has diverse clinical manifestations, making diagnosis challenging. Materials and Methods: We retrospectively reviewed 21 adults diagnosed with ocular syphilis at a tertiary referral center between 2018 and 2023. Diagnosis was based on compatible ophthalmologic findings, together with positive treponemal serology. Demographic, clinical, ophthalmologic, laboratory, cerebrospinal fluid (CSF), imaging, and treatment data were analyzed. Results: A total of 21 patients (30 eyes) were included. The majority were male (87%), with a median age of 44 years, and bilateral involvement occurred in 43% of patients. Blurred vision and decreased visual acuity were the most common presenting symptoms (80%). Uveitis (68.4%), predominantly posterior, and optic neuritis (42.1%) were the most frequent ophthalmologic findings. Serum VDRL was negative in 5 of 21 patients despite positive treponemal serology. Among the 14 patients who underwent lumbar puncture, half had normal cerebrospinal fluid findings. All patients received neurosyphilis-directed antimicrobial therapy. The mean baseline BCVA was 0.38 ± 0.30 logMAR (range, 0–1), improving to 0.16 ± 0.28 logMAR (range, 0–1) at the final follow-up. The improvement in BCVA following treatment was statistically significant (p < 0.001). No eye showed deterioration in BCVA after treatment; visual acuity either improved or remained stable in all eyes. Additionally, all cases of uveitis and optic neuropathy achieved clinical remission during follow-up. Conclusions: Ocular syphilis remains a diagnostic challenge because of its heterogeneous clinical manifestations and the occurrence of negative serum VDRL results or normal cerebrospinal fluid findings in patients who underwent lumbar puncture. These findings highlight the limitations of relying solely on non-treponemal serology or cerebrospinal fluid analysis when evaluating patients with suspected ocular syphilis.
Open AccessOcular Syphilis in the Era of Resurgence: Clinical Characteristics and Diagnostic Challenges in a Single-Center Cohort
Background and Objectives: The global resurgence of syphilis has been accompanied by an increasing number of ocular syphilis cases. Ocular syphilis can occur at any stage of infection and has diverse clinical manifestations, making diagnosis challenging. Materials and Methods: We retrospectively reviewed 21 adults diagnosed with ocular syphilis at a tertiary referral center between 2018 and 2023. Diagnosis was based on compatible ophthalmologic findings, together with positive treponemal serology. Demographic, clinical, ophthalmologic, laboratory, cerebrospinal fluid (CSF), imaging, and treatment data were analyzed. Results: A total of 21 patients (30 eyes) were included. The majority were male (87%), with a median age of 44 years, and bilateral involvement occurred in 43% of patients. Blurred vision and decreased visual acuity were the most common presenting symptoms (80%). Uveitis (68.4%), predominantly posterior, and optic neuritis (42.1%) were the most frequent ophthalmologic findings. Serum VDRL was negative in 5 of 21 patients despite positive treponemal serology. Among the 14 patients who underwent lumbar puncture, half had normal cerebrospinal fluid findings. All patients received neurosyphilis-directed antimicrobial therapy. The mean baseline BCVA was 0.38 ± 0.30 logMAR (range, 0–1), improving to 0.16 ± 0.28 logMAR (range, 0–1) at the final follow-up. The improvement in BCVA following treatment was statistically significant (p < 0.001). No eye showed deterioration in BCVA after treatment; visual acuity either improved or remained stable in all eyes. Additionally, all cases of uveitis and optic neuropathy achieved clinical remission during follow-up. Conclusions: Ocular syphilis remains a diagnostic challenge because of its heterogeneous clinical manifestations and the occurrence of negative serum VDRL results or normal cerebrospinal fluid findings in patients who underwent lumbar puncture. These findings highlight the limitations of relying solely on non-treponemal serology or cerebrospinal fluid analysis when evaluating patients with suspected ocular syphilis.